oral semaglutide
The Pill That Could Swallow the Market: Novo Nordisk’s Oral Wegovy and the New Frontier of Finance
Novo Nordisk’s US approval for an oral weight-loss pill ignites a new phase in its rivalry with Eli Lilly, reshaping the future of healthcare investing.